Afișare rezultate
Afisarea articolelor 1-1(1) pentru cuvîntul-cheie "
Sacubitril Plus Valsartan"
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes |
Bottcher Michael Friedrich1, Dungen Hans-Dirk2, Corcea Vasile3, Donath Frank4, Fuhr Rainard5, Gal Pim67, Mikus Gerd8, Trenk Dietmar9, Coenen Martin10, Pires Philippe Vieira11, Maschke Claudia12, Aliprantis Antonios Othon13, Besche Nina14, Becker Corina1 |
1 Clinical Pharmacology, Wuppertal, 2 Charité - University Medicine Berlin, 3 Timofei Moșneaga Republican Clinical Hospital, 4 SocraTec R and D GmbH, Erfurt, 5 Early Phase Clinical Unit, Berlin, 6 Centre for Human Drug Research, Leiden, 9 University Medical Center Freiburg, 11 Research and Development, Bayer AG, Wuppertal, 12 Study Management, Bayer AG, Wuppertal, 13 Translational Medicine, Merck and Co., Inc., New Jersey , 14 Chrestos Concept GmbH and Co. KG, Essen |
American Journal of Cardiovascular Drugs |
Nr. / 2023 / ISSN 1175-3277 /ISSNe 1179-187X |
Disponibil online 28 February, 2023. Descarcări-0. Vizualizări-228 |
-----------------------------------------------------------------------------------------------------------------------------------
1-1 of 1